{"public_id":"cl_09b174ae2e75f65575a130e8d33b3a10","status":"active","superseded_by_public_id":null,"corpus_id":25100921,"text":"PET-2 emerges as the single most important tool for planning risk-adapted treatment in advanced Hodgkin's lymphoma.","confidence":0.95,"paper":{"corpus_id":25100921,"title":"Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study.","url":"https://sah.borca.ai/papers/25100921"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_29fea76cdefea00b2cf184d99bbb9e6d","name":"risk-adapted treatment","description":"Treatment planning adjusted according to a patient's measured risk or prognostic profile.","types":["treatment strategy"],"url":"https://sah.borca.ai/concepts/co_29fea76cdefea00b2cf184d99bbb9e6d"},{"public_id":"co_a7a3894478d4f5347be438d8c3d9bef2","name":"FDG-PET scan","description":"An interim fluorodeoxyglucose positron emission tomography examination used to assess disease activity after initial chemotherapy.","types":["measurement technique","prognostic test"],"url":"https://sah.borca.ai/concepts/co_a7a3894478d4f5347be438d8c3d9bef2"},{"public_id":"co_d8e4efc53e12286513712331a2d1747b","name":"advanced Hodgkin's lymphoma","description":"Hodgkin's lymphoma at advanced stages, including stage IIB through IVB and selected stage IIA cases with adverse factors.","types":["condition"],"url":"https://sah.borca.ai/concepts/co_d8e4efc53e12286513712331a2d1747b"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_09b174ae2e75f65575a130e8d33b3a10"}